Advances in the treatment of patients with hemophilias

Abstract

This paper aims to discuss selected advances made recently for treating hemophilias consisting of the following; introducing new modified clotting factor concentrates for clinical use, successful gene therapy in patients with severe hemophilia B and successful long-term bleeding prevention in patients with severe hemophilia complicated by a high titre of factor VIII inhibitor.